We serve Chemical Name:2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate CAS:219492-81-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate
CAS.NO:219492-81-6
Synonyms:tert-butyl 4-amino-3-nitrophenylcarbamate;3-Nitroarsanilic acid;3-Nitro-4-amino-phenylarsinsaeure
Molecular Formula:C11H15N3O4
Molecular Weight:253.25400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:113.66000
Exact Mass:253.10600
LogP:3.64200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like tert-butyl 4-amino-3-nitrophenylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Nitro-4-amino-phenylarsinsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Nitroarsanilic acid Use and application,3-Nitroarsanilic acid technical grade,usp/ep/jp grade.
Related News: CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. 2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate manufacturer Active pharmaceutical ingredients directly impact disease. 2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate supplier Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. 2-Methyl-2-propanyl (4-amino-3-nitrophenyl)carbamate factory Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions.
